Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study

Efficacy and safety results of rituximab and bendamustine combination (Scheme BR) in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) are presented. From 01.2012 to 04.2013, the treatment was initiated in 43 patients (21 with relapses are sensitive to the last line of therapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: S. V. Semochkin, E. G. Arshanskaya, O. D. Zakharov, A. N. Kotelnikova, S. S. Kulikova, E. V. Ovanesova, Yu. B. Kochkareva, V. L. Ivanova
Formato: Artigo
Idioma:Russo
Publicado em: ABV-press 2015-06-01
Colecção:Onkogematologiâ
Assuntos:
chronic lymphocytic leukemia
relapse
refractory
bendamustine
rituximab
Acesso em linha:https://oncohematology.abvpress.ru/ongm/article/view/134
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados